CABA vs CCL · $143.9M cap vs P/E 15, rev $25.02B
Cabaletta Bio Inc (CABA) versus Carnival Corporation (CCL) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Carnival Corporation (CCL) is a travel services company listed on US.
CABA does not have a complete income-statement cache yet.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
CABA currently screens at market cap $143.9M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Not investment advice. Open the CABA and CCL stock pages for the full models.
Not investment advice.